Ranibizumab
Showing 51 - 75 of 714
Diabetic Macular Edema: Relevance of Staging Progression on
Recruiting
- Diabetic Macular Edema
- intravitreal administration of bevacizumab/ranibizumab/aflibercept/desamethazone
-
Lugano, SwitzerlandESASO Scientific Projects
Oct 4, 2021
Diabetic Retinopathy Trial in Puerto Rico, United States (PDS Implant Pre-Filled with 100 mg/mL Ranibizumab, Intravitreal
Active, not recruiting
- Diabetic Retinopathy
- PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
- Intravitreal Ranibizumab 0.5 mg Injection
-
Dothan, Alabama
- +75 more
Aug 3, 2022
Central Retinal Vein Occlusion Trial in Stockholm (Aflibercept, Ranibizumab)
Completed
- Central Retinal Vein Occlusion
- Aflibercept
- Ranibizumab
-
Stockholm, SwedenSt Eriks Eye Hospital
Dec 3, 2020
Neovascular Age-Related Macular Degeneration Trial in United States (PDS Implant filled with 100 mg/mL Ranibizumab, Intravitreal
Completed
- Neovascular Age-Related Macular Degeneration
- PDS Implant filled with 100 mg/mL Ranibizumab
- Intravitreal Injections of 10 mg/mL Ranibizumab
-
Mesa, Arizona
- +76 more
Feb 28, 2022
Neovascular Age-Related Macular Degeneration (nAMD) Trial in United States (RGX-314 Dose 1, RGX-314 Dose 2, Ranibizumab
Recruiting
- Neovascular Age-Related Macular Degeneration (nAMD)
- RGX-314 Dose 1
- +3 more
-
Phoenix, Arizona
- +14 more
Mar 29, 2022
Age-related Macular Degeneration (AMD) Trial in Worldwide (ranibizumab)
Completed
- Age-related Macular Degeneration (AMD)
- ranibizumab
-
Vienna, Austria
- +57 more
Sep 2, 2021
Diabetic Retinopathy, Macular Edema Trial in Cleveland (aflibercept)
Completed
- Diabetic Retinopathy
- Macular Edema
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
Jan 25, 2021
Exudative Age Related Macular Degeneration Trial in Charlotte, Statesville (Ranibizumab Injection [Lucentis])
Completed
- Exudative Age Related Macular Degeneration
- Ranibizumab Injection [Lucentis]
-
Charlotte, North Carolina
- +1 more
Oct 19, 2020
Diabetic Macular Edema Trial in Beverly Hills, West Columbia, Houston (Ranibizumab 0.3 mg intravitreal injection, Guided Laser
Completed
- Diabetic Macular Edema
- Ranibizumab 0.3 mg intravitreal injection
- Guided Laser Photocoagulation
-
Beverly Hills, California
- +2 more
Oct 23, 2020
Diabetic Retinopathy, Retinal Neovascularisation Trial in London (Ranibizumab, Saline)
Completed
- Diabetic Retinopathy
- Retinal Neovascularisation
- Ranibizumab
- Saline
-
London, United KingdomMoorfields Eye Hospital
Sep 7, 2020
Ocular Adverse Events in Neovascular Agerelated Macular
Completed
- Age-related Macular Degeneration (AMD)
- Aflibercept
- +2 more
-
East Hanover, New JerseyNovartis Investigative Site
Dec 15, 2021
Neovascular Age-related Macular Degeneration (nAMD) Trial in Worldwide (Ranibizumab, Port Delivery System with Ranibizumab)
Recruiting
- Neovascular Age-related Macular Degeneration (nAMD)
- Ranibizumab
- Port Delivery System with Ranibizumab
-
Capital Federal, Argentina
- +84 more
Aug 2, 2022
Retinopathy of Prematurity Trial in Worldwide (Ranibizumab)
Active, not recruiting
- Retinopathy of Prematurity
- Ranibizumab
-
Sacramento, California
- +72 more
May 23, 2022
Ophthalmopathy Trial in Asyut (Ranibizumab, triamcinolone acetate)
Unknown status
- Ophthalmopathy
- Ranibizumab
- triamcinolone acetate
-
Asyut, EgyptWael
Jul 2, 2020
Cytokeratin 8 Level in Age-related Macular Degeneration
Completed
- Age-related Macular Degeneration
- Ranibizumab
-
Goyang, Korea, Republic of
- +1 more
Dec 5, 2020
Diabetic Retinopathy Trial in London (Ranibizumab, Modified ETDRS laser)
Completed
- Diabetic Retinopathy
- Ranibizumab
- Modified ETDRS laser
-
London, United KingdomMoorfields Eye Hospital
Sep 7, 2020
Age Related Macular Degeneration Trial in China (HLX04-O,recombinant anti-vascular endothelial growth factor (VEGF) humanized
Recruiting
- Age Related Macular Degeneration
- HLX04-Oļ¼recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
- Lucentis
-
Bengbu, Anhui, China
- +40 more
Apr 27, 2022
Intravitreal Ranibizumab in Recurrent ROP
Completed
- Retinopathy of Prematurity
- intravitreal injection of Ranibizumab
-
Mansoura, Dakahlia, EgyptMansoura University
Aug 31, 2020
Branch Retinal Vein Occlusion Trial in BeiJing (601 1.25mg, Ranibizuman 0.5 mg)
Not yet recruiting
- Branch Retinal Vein Occlusion
- 601 1.25mg
- Ranibizuman 0.5 mg
-
BeiJing, Beijing, ChinaBeiJing Hospital
Dec 8, 2020
Neovascular Age Related Macular Degeneration Trial in Torrance (OCT, Multifocal ERG, Microperimetry, Ranibizumab Ophthalmic)
Completed
- Neovascular Age Related Macular Degeneration
- OCT, Multifocal ERG, Microperimetry
- Ranibizumab Ophthalmic
-
Torrance, CaliforniaRetina Macula Institute
Sep 1, 2020
Ocular Adverse Events in Neovascular Age-related Macular
Completed
- Age-related Macular Degeneration (AMD)
- Aflibercept
- +2 more
-
East Hanover, New JerseyNovartis Investigative Site
Dec 15, 2021
OCTA and Polypoidal Choroidal Vasculopathy
Completed
- Polypoidal Choroidal Vasculopathy
- Ranibizumab Injection
-
Naples, ItalyUniversity of Naples "Federico II"
Jan 14, 2021
Age-Related Maculopathy, Choroidal Neovascularization Trial in Tulsa (Ranibizumab, Verteporfin)
Completed
- Age-Related Maculopathy
- Choroidal Neovascularization
- Ranibizumab
- Verteporfin
-
Tulsa, OklahomaEagle Mountain Vision
Nov 4, 2020